BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10764738)

  • 1. Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments.
    Jensen PH; Islam K; Kenney J; Nielsen MS; Power J; Gai WP
    J Biol Chem; 2000 Jul; 275(28):21500-7. PubMed ID: 10764738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
    Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-Synuclein filaments bind the transcriptional regulator HMGB-1.
    Lindersson EK; Højrup P; Gai WP; Locker D; Martin D; Jensen PH
    Neuroreport; 2004 Dec; 15(18):2735-9. PubMed ID: 15597044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.
    Spillantini MG; Crowther RA; Jakes R; Hasegawa M; Goedert M
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6469-73. PubMed ID: 9600990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies.
    Gai WP; Yuan HX; Li XQ; Power JT; Blumbergs PC; Jensen PH
    Exp Neurol; 2000 Dec; 166(2):324-33. PubMed ID: 11085897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
    Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function.
    Tofaris GK; Razzaq A; Ghetti B; Lilley KS; Spillantini MG
    J Biol Chem; 2003 Nov; 278(45):44405-11. PubMed ID: 12923179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of human alpha-synuclein in different cytoskeletons in Lewy bodies in brains of dementia with Lewy bodies.
    Iseki E; Marui W; Sawada H; Uéda K; Kosaka K
    Neurosci Lett; 2000 Aug; 290(1):41-4. PubMed ID: 10925170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry.
    Braak H; Sandmann-Keil D; Gai W; Braak E
    Neurosci Lett; 1999 Apr; 265(1):67-9. PubMed ID: 10327208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of heparan sulfate proteoglycans in Lewy bodies and Lewy neurites in Parkinson's disease brains.
    van Horssen J; de Vos RA; Steur EN; David G; Wesseling P; de Waal RM; Verbeek MM
    J Alzheimers Dis; 2004 Oct; 6(5):469-74. PubMed ID: 15505367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Synuclein is phosphorylated in synucleinopathy lesions.
    Fujiwara H; Hasegawa M; Dohmae N; Kawashima A; Masliah E; Goldberg MS; Shen J; Takio K; Iwatsubo T
    Nat Cell Biol; 2002 Feb; 4(2):160-4. PubMed ID: 11813001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Uéda K; Sunohara N; Hirai S; Izumiyama Y; Tonozuka-Uehara H; Kawai M
    Brain Res; 1998 Oct; 808(1):93-100. PubMed ID: 9795161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
    Spillantini MG; Crowther RA; Jakes R; Cairns NJ; Lantos PL; Goedert M
    Neurosci Lett; 1998 Jul; 251(3):205-8. PubMed ID: 9726379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.
    Jensen PH; Nielsen MS; Jakes R; Dotti CG; Goedert M
    J Biol Chem; 1998 Oct; 273(41):26292-4. PubMed ID: 9756856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
    Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T
    Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease.
    Mezey E; Dehejia AM; Harta G; Tresser N; Suchy SF; Nussbaum RL; Brownstein MJ; Polymeropoulos MH
    Mol Psychiatry; 1998 Nov; 3(6):493-9. PubMed ID: 9857974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
    Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
    Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies.
    Lindersson E; Lundvig D; Petersen C; Madsen P; Nyengaard JR; Højrup P; Moos T; Otzen D; Gai WP; Blumbergs PC; Jensen PH
    J Biol Chem; 2005 Feb; 280(7):5703-15. PubMed ID: 15590652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA; Harper JD; Lansbury PT
    Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein/phospholipase C (PLCbeta1) interactions.
    Dalfó E; Albasanz JL; Martin M; Ferrer I
    Brain Pathol; 2004 Oct; 14(4):388-98. PubMed ID: 15605986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.